Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sitagliptin (januvia) (1 trial)
ht047 (1 trial)
Cerebral Infarction (Phase 2)
Ischemia (Phase 2)
Prediabetic State (Phase 4)
Stroke (Phase 2)
Trials (2 total)
Trial APIs (2 total)